The aim of the present study is to evaluate the involvement of human neutrophil tyrosine kinase(s) in the signal transduction mechanism of granulocyte-macrophage colony-stimulating factor (GM-CSF). Stimulation of neutrophils with GM-CSF resulted in a time-and dose-dependent phosphorylation of several proteins having estimated molecular weights of approximately 40, 55, 74, 97, 118, and 155 Kd, detected by immunoblot using a monoclonal antibody directed against phosphotyrosine. OM-CSF-induced tyrosine phosphorylation was inhibited in a dose-and time-dependent manner by the tyrosine kinase inhibitor erbstatin. Using this inhibitor, we were able to correlate tyrosine phosphorylation with RANULOCYTE-MACROPHAGE colony-stimulat-G ing factor (GM-CSF), a 22-Kd cytokine derived from activated cells of the immune system, such as T lymphocytes, macrophages, fibroblasts and endothelial cells, is a growth factor involved in the proliferation and maturation of progenitor cells of the hematopoietic
phate) (GTP) yS-induced oxy-radical produ~tion'~,'~ and mobilization of intracellular calcium'' stimulated by fMetLeu-Phe are also enhanced by GM-CSF. More recently, GM-CSF was shown to enhance leukotriene synthesis induced by A23187, Met-Leu-Phe, and C5a,lbm and plateletactivating factor (PAF) production by Met-Leu-Phe and C5a in human neutrophils."
Studies to date have not yet made significant inroads into the pathways of signal transduction by which cytokines, including CSFs and growth factors, exert their effects on different cells after binding to their surface receptors. We and others have recently reported the existence of both pertussis toxin-sensitive and insensitive pathways involved in the actions of GM-CSF on mature human neutrophils.12~16~"~23 These results, apart from implicating G proteins in the signal transduction of GM-CSF, also raise the possibility of multiple pathways in the biologic effects of these cytokines. Recent studies also indicate that incubation of various cell types, including neutrophils, with GM-CSF stimulates the tyrosine phosphorylation of several proteins, thus raising the possibility that tyrosine kinase activation may be required for the biologic activity of GM-CSF.22,"-27 Recent evidence based on the deduced amino acid sequences of two human GM-CSF receptor subunit cDNAs suggests that this receptor does not possess a tyrosine kinase Therefore, we have conducted studies aimed at determining the extent of the involvement of neutrophil tyrosine kinase activation in the biologic effects of GM-CSF on these cells. To achieve this, we have examined the effects of erbstatin, a highly selective tyrosine kinase inhibitor isolated from culture filtrates of Streptomyces viridosporus,30~31 on direct and priming actions of GM-CSF on human peripheral blood neutrophils.
MATERIALS AND METHODS

Materials. N-formyl-Methionyl-Leucyl-Phenylalanine (fMet-
Leu-Phe) and diisopropylfluorophosphate (DFP) were obtained from the Sigma Chemical Company (St Louis, MO). Hank's Balanced Salt Solution (HBSS) was obtained from GIBCO (Burlington, Ontario, Canada). Ficoll-Paque was obtained from Pharmacia (Dorval, QuCbec, Canada). Biosynthetic recombinant human GM-CSF was a generous gift from the Genetics Institute (Cambridge, MA). The GM-CSF was stored at 4"C, at a stock concentration of 100 nmol/L in phosphate-buffered saline containing 0.01% bovine serum albumin (BSA, Sigma). Tests on this solution using the Limulus amebocyte assay for lipopolysaccharide were negative. All products used for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting were reagent grade and purchased from Sigma. 'H-leukotriene B, (specific activity 191 to 210 Ci/mmol) was purchased from the Amersham Corporation (Arlington, IL). All reagents used for Northern blots were molecular biology grade and were purchased from Sigma. FURA-2/AM and BCECF were purchased from Molecular Probes (Eugene, OR). Erbstatin was a generous gift from Dr K. Umezawa (Institute of Microbial Chemistry, Tokyo, Japan).
Whole blood was obtained by venepuncture, collected into tubes containing heparin, and after dextran sedimentation neutrophils were purified by centrifugation on Ficoll-Paque cushions." Contaminating erythrocytes were removed by hypotonic lysis and the cells were resuspended in HBSS containing Ca'+ (1.6 mmol/L) at a final concentration of 5 X lo6 cells/mL. The percentage of neutrophils in the cell preparations used in this study exceeded 97% and cell viability as determined by trypan blue exclusion was greater than 98%. The entire separation was performed at room temperature.
Intracellular free calcium was monitored using the fluorescent probe fura-2 as described by Naccache et al." Briefly, neutrophil suspensions (1 x lo7 cells/ml) were incubated with 10 p,g/mL erbstatin for 1 hour at 37°C followed by a further incubation at 37°C with GM-CSF and 1 kmol/L FURA-2/AM for 30 minutes. The cells were then washed free of the extracellular probe, resuspended at 5 x 106 cells/mL, and allowed to re-equilibrate for 10 minutes at 37°C. They were then transferred to the thermostatted cuvette compartment (37°C) of the fluorimeter and the fluorescence was monitored (excitation and emission wavelengths, 340 and 510 nm, respectively), and calibrated as described previously."
Neutrophils were prepared as described previously, resuspended at 2 x 10' cells/mL in HBSS and treated with either erbstatin or dimethyl sulfoxide (DMSO) for 1 hour at 37°C followed by treatment with either GM-CSF or diluent control for a further 30 minutes at 37°C. The cells were then rapidly centrifuged and either frozen in a solution of dry ice/ethanol and stored at -70°C until used or processed directly. Total RNA was purified using a solution of guanidium isothiocynate (6 mol/L guanidium isothiocyanate, 20 nmol/L sodium acetate pH 5.2, 0.1 mmol/L dithiothreitol, 0.5% sarkosyl, and 1% mercaptoethanol) and centrifugation through a cesium chloride gradient essentially as previously described." Electrophoresis was then performed on a 1% agarose gel. Integrity of RNA and equal loading was verified by ethidium bromide staining and by hybridization with a cDNA probe that nonspecifically anneals with ribosomal RNA. The RNA was transferred onto Hybond-N membranes (Millipore Corporation, Bedford, MA) using a vacugene apparatus (Bio-Rad, Montreal, Quebec). Hybridization and posthybridization washes were performed under stringent conditions as previously described." A c-fos cDNA clone (a generous gift from Dr Raymond Vincent, Centre Hospitalier Robert Giffard, Quebec, Canada) labeled using the "Random Primer Method" (BRL Canada, Burlington, Ontario) was used for all hybridizations. The Northern blots were visualized by autoradiography with Kodak X-Omat films (Picker, Montreal, Quebec, Canada).
['251]-GM-CSFbindingto neutrophils. Recombinant human GM-CSF was iodinated to a specific activity of 4.8 x lo'* dpm/mol by the Bolton Hunter method.'' The iodinated GM-CSF remained biologically active.% Cells used for the binding experiments were washed once and resuspended in binding buffer (Iscove's modified Dulbecco's medium containing 25 mmol/L HEPES and 2 mg/mL BSA, pH 7.4) at a concentration of lo7 cells/mL. For the experiments studying the effect of erbstatin on the binding of GM-CSF to Cell separation.
Measurement of intracellular calcium.
c-fos mRNA expression. neutrophils, 200 p,L of the cells was preincubated with 10 p,g/mL erbstatin or DMSO control for 1 hour at 37°C. The cells were incubated with '251-labeled GM-CSF at various concentrations in the presence or absence of a 50-fold excess of cold GM-CSF for 2 hours at 23°C. After the incubation, the cells were resuspended and transferred onto 0.75 mL of an ice-cold solution of 75% fetal bovine serum (FBS) in binding buffer. The cells were then centrifuged for 2 minutes in a microcentrifuge, the supernatant was aspirated, and the pellets were sliced off with a razor blade for the determination of their radioactivity. Specific binding was defined as the amount of binding blocked by a 50-fold excess of unlabeled Data from these binding experiments were analyzed by weighted nonlinear least squares curve fitting developed by Munson and R~dbard.'~ Objective statistical criteria (F-test, extra sum squares principle) were used to evaluate goodness-of-fit and for discriminating between models. Curves from multiple experiments were analyzed both individually and simultaneously using constrained curve fitting to obtain precision of parameter estimates. Nonspecific binding was treated as a parameter subject to error and was fitted simultaneously with other parameters. Neutrophils were purified as described previously and resuspended in binding buffer GM-CSF.
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CP~[~H]-LTB, Bound With Diluent
-cpm Bound With GM-CSF cpm Bound With Diluent Control -cpm Bound With lOOX Excess LTB, Intracellular pH measurement. Intracellular pH was monitored using the fluorescent probe BCECF essentially as previously Briefly, neutrophil suspensions ( lo7 cellsiml) were incubated with either 10 p,g/mL erbstatin or the equivalent volume of DMSO for 1 hour at 37°C. BCECF (4 kmol/L) was added during the final 30 minutes of the incubation. The cells were then washed free of the probe which remained in the extracellular milieu, resuspended at 3 x 106 cells/mL, incubated for 10 minutes at 3TC, transferred to a thermostatically controlled, magnetically stirred cuvette compartment of a fluorometer (SLM 8000; SLM Instruments Inc, Urbana, IL), and the fluorescence intensity was monitored (emission and excitation wavelengths of 500 and 530 nm, respectively). The fluorescent signals were calibrated by lysing the cells with 0.1% Triton X-100 (Sigma) and recording the fluorescence of the signals at varying pH values. A correction value of 0.15 pH units was applied to the calculated values of intracellular pH as described previously'8-M and the spectra were normalized with respect to the slope of the relationship between the changes in fluorescence and the pH to account for variations in the amounts of cell-incorporated BCECF and for quenching.
Neutrophils were incubated at 5 x lo6 cells/mL with 1.0 mmol/L DFP for 5 minutes at 37°C before stimulation for varying periods of time with either DMSO, fMet-Leu-Phe mol/L), diluent control (0.01% BSA), or GM-CSF. The reactions were terminated by rapid centrifugation,
Western blots for phosphotyrosine.
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From the supematants were discarded, and the pellets were resuspended in 70 pL of an ice-cold stopping solution (Ca'* free HBSS, 10 mmol/L HEPES at pH 7.4, 2 mmol/L Na orthovanadate. 10 mmol/L NaF. 10 mmol/L nitrophosphate, 10 mmol/L Na pyrophosphate, 1 mmol/L EGTA. 1 mmol/L phenylmethylsulfonyl fluoride (PMSF], I O @mL leupeptin, and 10 &mL aprotinin). Seventy microliters of the sample buffer (l0V mercaptoethanol, 10% glycerol, 8% SDS in Tris-HCI, pH 6.8) was then added and the samples were denatured by boiling for 5 minutes and loaded onto a 5 5 to 15% SDS polyacrylamide gel. Electrophoretic transfer cells (Hoeffer Scientific Instruments, Canberra Packard Canada, Mississauga. Ontario) were used to trangfer proteins from the polyacrylamide gels to lmmobilon PDVF membranes (Millipore). Nonspecific sites were hlocked using 3c/r BSA for 1 hour at 37°C. The monoclonal antiphosphotyrosine antibody PY20 (ICN Biomedical, Montreal, Quebec. Canada) was then incubated with the membranes overnight at 4°C at a final dilution of l:l,OOO. The membranes were washed at room temperature six times in TBS-Tween 20 solution (25 mmol/L Tris HCI. pH 8.0, I90 mmol/L NaCI, 0.05% vol/vol Tween 20) for 10 minutes each. The washed membranes were then incubated with a ["'I]-labeled goat antimouse lgG (labeled to a specific activityof 7 to 10 pCi/Fg) for 1 hour at 37°C and washed six times as described previously. The phosphotyrosine bands were then visualized by autoradiography by exposing the membranes to Kodak X-Omat films overnight at -7VC.
RESULTS
Effect of GM-CSF on neutrophil p x i n e kinase phosphory-
lation. Neutrophils wcrc incubated with diffcrcnt conccntrations of GM-CSF (or dilucnt) for varying periods of time, or with fMct-Lcu-Phc or DMSO (the dilucnt for Met-LeuPhc) for 1 minutc, and the incubations wcrc stopped by rapid centrifugation. The pcllcts wcrc then rcsuspcndcd in sample buffer, processed for SDS-PAGE, transfcrrcd onto Immobilon-P membranes, and the tyrosine phosphoprotcins wcrc idcntificd by Westcrn blot using a spccific antiphosphotyrosinc monoclonal antibody. In cach cxpcrimcnt, wc stimulatcd thc cells for 1 minutc at 37°C with IO-' mol/L fMct-Leu-Phc as a "positive control" bccausc we and others have previously shown that fMct-Leu-Phc stimulates tyrosine phosphorylation in ncutrophils,?h.l'.'' and we have rcccntly demonstratcd that crbstatin inhibits this effect of Mct-Leu-Phc." In the present study, incubation of ncutrophils with fMct-Leu-Phc stimulatcd the phosphorylation of two proteins having estimated molecular wcights of approximatcly 40 and 118 Kd (Fig 1) . Using fMct-LcuPhc as an agonist, phosphorylation of the 40-Kd band was the most strongly and consistently enhanccd over an additional 30 cxpcrimcnts. Exposure of neutrophils to GM-CSF resulted in the dosc-dcpcndcnt tyrosinc phosphorylation of ncutrophil proteins. A dosc-rcsponsc curve to GM-CSF (20 minutes at 37°C) from onc representative experiment is shown in Fig 1. Similar results wcrc sccn in eight additional cxpcrimcnts. Visual assessment of autoradiographs indicatcd that the effect of GM-CSF on ncutrophil tyrosine phosphorylation was maximal at concentrations bctwccn 1 and 3 nmol/L. Over the entire study, GM-CSF most consistently stimulated the tyrosine phosphorylation of scvcral protcins having molecular wcights of approximatcly 40, 55, 74. 97, 118, and 155 Kd, although at times the tyrosine phosphorylation of up to 10 diffcrcnt bands was obscrvcd (data not shown). Dcnsitomctric analysis of the phosphotyrosine bands in the autoradiograph shown in Fig 1 provides a quantitativc assessmcnt of the effect of GM-CSF on the tyrosine phosphorylation of each of these protcins (Fig 2) . Thc amounts of all six phosphoprotcins inereascd rclativc to the control (ic. cclls incubatcd with 0.01% BSA) in a dose-depcndcnt manner aftcr stimulation with GM-CSF. Tyrosinc phosphorylation in responsc to GM-CSF was observed whcn the cclls wcrc stimulated with conccntrations of GM-CSF bctwccn 100 and 300 pmol/L. Maximal tyrosine phosphorylation occurrcd upon stimulation of the cclls with bctwccn 1 and 3 nmol/L GM-CSF. It should bc notcd that some variability with rcspcct to thc rclativc incrcasc in tyrosine phosphorylation of each band was also obscrvcd bctwccn cxpcrimcnts; howcvcr, over thc cntirc study thc tyrosinc phosphorylation of all six of thcsc proteins was consistcntly cnhanccd.
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Ncutrophils wcrc stimulated with 1 nmol/L GM-CSF at 37°C for various periods of time and blotted for phosphotyrosinc protcins as dcscribcd previously. An autoradiograph from a rcprcscntativc cxpcrimcnt is shown in Fig 3, indicating that thc cffcct of GM-CSF was timc-dcpcndcnt. Dcnsitomctric analysis of this cxpcrimcnt is shown in Fig 4. Similar results wcrc sccn in five othcr cxpcrimcnts. Control studies showed that thc lcvcl of tyrosine phosphorylation in nonstimulatcd cclls (cclls incubated with 0.01% BSA) did not significantly change over a period of 120 minutes (data not shown). In contrast, an cffcct of GM-CSF on tyrosine phosphorylation was consistently obscrvcd aftcr a minimum stimulation time of bctwccn 1 and 5 minutes. Thc tyrosine phosphorylation induced by GM-CSF followcd two diffcrcnt temporal patterns, onc whcrc thc maximal cffcct was rcachcd with bctwccn 15 and 30 minutes of stimulation aftcr which thc tyrosine phosphorylation rapidly dccrcascd (this was apparcnt for thc 74-, 97-, 11%. and 155-Kd proteins), and thc second group (thc 40-and 55-Kd phosphoprotcins) whosc lcvcl of phosphorylation continued to incrcasc with up to 120 minutes of stimulation.
Eflect of erbstatin on GM-CSF-induced tyrosine pho.yphorylation. To dctcrminc whether thc tyrosine phosphorylation obscrvcd with GM-CSF was inhibitable with crbstatin, neutrophils wcrc prcincubatcd for 1 hour at 37°C with cithcr DMSO or 5 or 10 pg/mL crbstatin. The cells wcrc then stimulated with 10 nmol/L GM-CSF for 20 minutes and thc samples wcrc immunoblottcd using thc antiphosphotyrosine antibody as dcscribcd prcviously. Thc phosphorylation of all thc phosphotyrosinc bands was dosc-dcpcndcntly inhibited aftcr prctrcatmcnt of thc ncutrophils with crbsta- tin. A rcprcscntativc cxpcrimcnt is shown in Fig 5. Thc autoradiograph from this cxpcrimcnt was also analyzcd by dcnsitomctry (Fig 6) and showed thc magnitude of thc inhibition by crbstatin of thc tyrosine phosphorylation induced by GM-CSF. Thcrc was little cffcct of crbstatin at 5 pg/mL crbstatin. In fact, only the 155-Kd phosphoprotcin was significantly affcctcd. However, preincubation with 10 pg/mL crbstatin complctcly inhibited tyrosine phosphoryla- 
phosphorylation induccd by fMct-Leu-Phc was consistcntly inhibitcd (data not shown).
Effict of erhstatin on the binding of GM-CSF to neutrophik Prcvious rcports havc dcmonstratcd inhibition of fMct-LeuPhc-induccd tyrosinc phosphorylation in neutrophils by ST638. Howcvcr, this compound also inhibitcd thc binding of fMct-Lcu-Phc to its ccll surfacc rcccptor, thcrcby rcndcring it impossiblc to draw mcaningful conclusions conccrning thc point at which activation of a tyrosinc kinasc may havc bccn involvcd in thc fMct-Lcu-Phc signal transduction pathway." Thcrcforc, wc conductcd cxpcrimcnts to dctcrrninc whcthcr or not crbstatin was inhibiting GM-CSFinduccd tyrosinc phosphorylation by intcrfcring with thc binding of GM-CSF to its rcccptors. Ncutrophils wcrc thcrcforc incubatcd for 1 hour with 10 pg/mL crbstatin as dcscribcd (SCC Matcrials and Mcthods). Prctrcatmcnt of ncutrophils with 10 pg/mL crbstatin did not altcr thc kd or the numhcr of GM-CSF rcccptors mcasurcd on human ncutrophils. A scatchard plot from a rcprcscntativc cxpcrimcnt is shown in Fig 7. Similar rcsults wcrc obtaincd in thrcc othcr cxpcrimcnts. Thc rclcvant data arc summarizcd in Tablc 1.
Effi~t of erhstatin on the alteration in intracellular pH induced bv GM-CSF. Ncutrophils wcrc prctrcatcd with the fluorcsccnt probc BCECF as dcscribcd in Matcrials and Mcthods and thc cffcct of GM-CSF on intraccllular pH was studicd. Within 5 minutcs, GM-CSF dircctly induccd an intraccllular alkalinization (Fig 8) . This cffcct was doscdcpcndcnt and thc maximal rcsponsc was sccn using conccntrations of GM-CSF of bctwccn 100 and 1,000 pmol/L. This rcsponsc was consistcnt with prcviously rcportcd rcsults.'" Thc minor acidification obscrvcd in this particular cxpcrimcnt was not consistcntly obscrvcd and Neutrophiis were incubated with 10 bg/mL erbstatin or diluent control (the equivalent volume of DMSO) for 1 hour at 37°C. The binding of GM-CSF to its cell surface receptor was then measured as described (see Materials and Methods). Data represent the mean 2 SD from three separate experiments.
GM-CSF STIMULATES TYROSINE PHOSPHORYLATION
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occurred in approximately half of the experiments performed. To determine whether or not tyrosine kinase activation was required for this effect of GM-CSF, neutrophils were preincubated with 10 pg/mL erbstatin or the equivalent volume of DMSO for 1 hour at 37°C. BCECF was added during the final 30 minutes of the incubation. The cells were then washed and intracellular pH in response to GM-CSF was measured. Erbstatin completely inhibited the alkalinization induced by GM-CSF (Fig 8) . As previously reported,4l erbstatin by itself had no effect on intracellular pH.
Effect of erbstatin on the GM-CSF-induced decrease in the sugace receptor expression of the leukotriene B, receptor. Neutrophils were preincubated with GM-CSF for 45 minutes at 37°C and assayed for leukotriene B, receptor expression. GM-CSF dramatically reduced the binding of 3H-leukotriene B, to its receptor on human neutrophils (Fig  9A) . The specific binding of 4 nmol/L 'H-leukotriene B, was reduced by 92.5% f 7% (n = 7) when neutrophils were pretreated with 1 nmol/L GM-CSF for 45 minutes at 37°C (Fig 9B) . Pretreatment of the neutrophils with erbstatin completely reversed the downregulation of the leukotriene B, receptor (Fig 9B) . Erbstatin by itself had no effect on the binding of 3H-leukotriene B, to untreated neutrophils (data not shown).
Effect of erbstatin on the increase in intracellular calcium mobilization induced by GM-CSF. We have previously observed that while GM-CSF by itself does not significantly alter the resting level of intracellular calcium, preincubation of neutrophils with GM-CSF leads to an increased calcium mobilization in response to subsequent stimulation by chemotactic factors such as met-Leu-Phe. Furthermore, we have recently shown that the intracellular calcium mobilization induced by chemotactic factors is not mediated by tyrosine kinase activity because this response was not inhibited by erb~tatin.~' Therefore, we conducted experiments to determine whether the priming action of GM-CSF on chemotactic factor-induced calcium fluxes could be inhibited by erbstatin. Neutrophils were incubated as described with or without erbstatin followed by a further incubation with the intracellular calcium probe FURA-2/AM with or without GM-CSF for 30 minutes at 37°C. Intracellular calcium mobilization studies were then performed as described (see Materials and Methods). As reported previously, erbstatin had no effect on the mobilization of calcium induced by fMet-Leu-Phe, and GM-CSF significantly enhanced the ability of fMet-Leu-Phe to increase intracellular calcium levels (Fig 10) . In contrast, pretreatment of the cells with erbstatin before incubation with GM-CSF completely abrogated the priming by GMc-fos2.2 kb-CSF of Met-Leu-Phe-induced calcium mobilization. The same results were observed using either leukotriene B, or PAF in place of Met-Leu-Phe as the second signal (data not shown).
Effect of erbstatin on the expression of c-fos mRNA induced by GM-CSF. To determine whether the stimulatory effect of GM-CSFon neutrophil gene expression is under tyrosine kinase control, neutrophils were pretreated with erbstatin as described, and stimulated with either GM-CSF or diluent control (0.01% BSA) for a further 30 minutes. Total RNA was then prepared and processed for analysis of the expression of mRNA for the proto-oncogene c-fos. As previously reported,u control neutrophils exhibited a minor constitutive expression of c-fos mRNA (Fig 11, lane A) that was enhanced after stimulation of the cells with GM-CSF for 30 minutes (Fig 11, lane B) . This enhanced expression' of c-fos mRNA induced by GM-CSF was significantly inhibited by pretreatment with erbstatin (Fig 11, lane C) . In these experiments, erbstatin also exhibited an inhibitory effect on the nonstimulated levels of c-fos mRNA (Fig 11,  lane D) , most likely indicating that the constitutive expression of c-fos is also under tyrosine kinase control. Densitometric analysis of each of three experiments showed the same overall trend (Fig 12) . GM-CSF consistently stimulated a threefold increase in c-fos mRNA levels and this enhancement was significantly inhibited by pretreatment with erbstatin.
DISCUSSION
The activities of many growth factors and other cytokines appear to be very closely associated with stimulation of a variety of tyrosine kinases. For example, the receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulinlike growth factor (IGF), fibroblast growth factor (FGF), and macrophage-CSF (M-CSF) contain tyrosine kinase domains and tyrosine-phosphorylate specific substrates."' Furthermore, alterations in tyrosine kinase domains of such receptors results in an altered growth and transforming ability of these receptor-ligand systems."6 In addition, it has recently come to light that protein tyrosine kinases may also play an important role in the activation pathways of terminally differentiated cells. f~ and that these tyrosine kinases may play important roles in the cellular activation mechanismswithin both hematopoietic and nonhematopoietic cells." Indeed, it is clear at this time that several "classical" neutrophil agonists such as the chemotactic factors fMet-Leu-Phe, lcukotriene B,, and C5a stimulate neutrophil tyrosine kinases4'.*' that are critical for superoxide production and alteration of intracellular pH, but do not appear to be involved in others such as calcium mobilization, actin polymerization, and degranulation."
In the current study, we have extended the observation that tyrosine kinase(s) is/are involved in certain intracellular pathways of neutrophil activation by chemotactic factors to include both direct and priming effects GM-CSF on human neutrophils. Three of the direct effects of GM-CSF on neutrophils were abrogated by the selective tyrosine kinase inhibitor erbstatin. These included alteration of intracellular pH, downregulation of the leukotriene B, receptor, and accumulation of mRNA for the protooncogene c-f0.s. In addition, we have shown that erbstatin inhibited the priming by GM-CSF for enhanced calcium mobilization in response to Wet-Leu-Phe. Finally, we demonstrated that erbstatin inhibited GM-CSF-induced tyrosine phosphorylation of at least six substrates in human neutrophils. These effects of erbstatin could not be explained by an attenuation of GM-CSF binding to its cell surface receptor because multiple experiments failed to demonstrate an effect of erbstatin on "'I-GM-CSF binding to human neutrophils.
While it is possible that the inhibition of the effects of GM-CSF by erbstatin is due to interference of as yet unknown signal transduction pathways in neutrophils, our results indicate that the inhibition of GM-CSF-induced neutrophil activation by erbstatin closely correlated the inhibitory effects of erbstatin on GM-CSF-induced tyrosine kinase activation in both a temporal and dose-dependent manner. Therefore, it is quite likely that erbstatin inhibits the stimulation of human neutrophils by GM-CSF by interfering with the activation of one or more tyrosine kinases. Moreover, previous studies with this compound have indicated that its inhibitory effects are highly selective for tyrosine kinases. For instance, it has been established that erbstatin inhibits semi-purified EGF receptor autophosphorylation in A431 cells,w and inhibits tyrosine kinase activation by competing with peptide substrates for the active site of the EGF receptor kinase." In addition, erbstatin has been shown to be without effect on purified protein kinase C (PKC) or protein kinase A (PKA)," although it has recently been shown that high concentrations of erbstatin (approximately twofold to fivefold greater than those used in the present study) inhibited PKC activity in a cell-free system. However, in the same report erbstatin was without effect on the PKC-mediated phosphorylation in intact cells." Apart from these previous demonstrations attesting to the specificity of erbstatin for tyrosine kinases (at least in intact cells), it has also repeatedly been shown that the effect of GM-CSF in neutrophils is not mediated by PKC.a'w In addition, we have recently shown that erbstatin blocks fMet-Leu-Phe-induced tyrosine phosphorylation in neutrophils without inhibiting phospholipase C activation or degranulation induced by fMet-Lcu-Phe." These latter results indicate that erbstatin is not toxic to neutrophils.
Human peripheral blood neutrophils appear to express only one class of GM-CSF receptor, a high-affinity receptor with a kd of approximately 100 to 300 pmol/L." At these concentrations, the effect of GM-CSF on tyrosine phosphorylation was observed most dramatically on the I S -, 118-, 97-, and 74-Kd substrates. In fact, the effect of GM-CSF on the 55-and 40-Kd substrates was not usually apparent unless the cells were stimulated with concentrations of GM-CSF of 1 nmol/L or greater. In addition, the time course experiments with GM-CSF indicated the presence of at least two temporally distinct groups of substrates. In one group, the proteins were rapidly phosphorylated after stimulation by GM-CSF (155, 118-, 97-, and 74-Kd substrates). Maximal phosphorylation of these proteins occurred within 5 to 15 minutes after stimulation and declined rapidly, approaching control levels after 60 minutes of stimulation. The second group (40-and 55-Kd substrates) were phosphorylated more slowly and reached maximal levels after 60 to 120 minutes of stimulation. These observations indicate that the effect of GM-CSF on the first four substrates may have more physiologic relevance than its effect on the 40-and 55-Kd substrates, or alternatively, that these two sets of substrates may be involved in different actions of GM-CSF. Evidence in support of the latter theory derives from previous studies indicating differences in the preincubation times required for the maximal priming effect of GM-CSF on distinct neutrophil functions such as calcium mobilization, leukotriene synthesis, and superoxide production.' " 17. " Several recent studies using a variety of different cell types ranging from interleukin-3 (IL-3)-and GM-CSFdependent human and murine cell lines to fully differentiated cells such as human neutrophils have demonstrated a large number of tyrosine phosphoproteins of varying molecular weights after stimulation with GM-CSF. Our present results are best related to those of Gomez-Cambronero et For personal use only. on October 23, 2017. by guest www.bloodjournal.org From a]?" who showed in two separate studies that GM-CSF stimulates tyrosine phosphorylation of proteins having molecular weights of 40, 54, 78, 92, and 118 Kd (although the 118-Kd phosphoprotein was only observed in one of the studies). However, in our study we found that the major effect of GM-CSF was on the tyrosine phosphorylation of a 155-Kd protein (see Fig 1,3, and 5) . The tyrosine phosphorylation of this protein was enhanced up to 50-fold by GM-CSF. Furthermore, in our studyy phosphorylation of the 74-and 118-Kd proteins were enhanced up to threefold and fourfold after stimulation by GM-CSF. These findings are in contrast to those of Gomez-Cambronero et a1,22.26 who did not report finding a 155-Kd phosphotyrosine protein and indicated that the 40-and 55-Kd proteins were most consistently and strongly phosphorylated by GM-CSF. The reasons for these variations are presently unclear but may be related to the fact that we used a monoclonal antiphosphotyrosine antibody that may have provided greater (or different) sensitivity and specificity than the polyclonal antibody used in their study.
In the current report, we have presented data that indicate at least four of the functional consequences of tyrosine kinase activation by GM-CSF in human neutrophils. However, the specific mechanism by which GM-CSF receptor-binding activates cellular tyrosine kinases remains unknown. Studies with pertussis toxin have indicated that the GM-CSF receptor is functionally linked to a G protein,'2~21s22z and it has been reported that pertussis toxin inhibits the ability of GM-CSF to tyrosine phosphorylate at least some of the phosphoproteins detected in neutrophils.% In addition, the recent cloning and sequencing of both low and high-affinity human GM-CSF receptor subunits has indicated a lack of tyrosine kinase domain^?^,^^ These results strongly suggest that the stimulation of neutrophil tyrosine kinase activity by GM-CSF occurs at a step distal to a G protein, Further studies are presently being performed in an attempt to better define this pathway.
While the precise mechanism by which GM-CSF both directly stimulates and primes neutrophils for increased responses to second signals remains unknown, the key to understanding the details of the GM-CSF signal transduction pathways in mature neutrophils is likely to lie in the identification of one or all of the proteins whose tyrosine phosphorylation is enhanced when neutrophils are stimulated with GM-CSF and of the specific tyrosine kinases whose activities are altered by GM-CSF. Several recent studies may provide an indication of the possible identity of some of these phophotyrosine proteins. Of particular relevence may be the fact that stimulation of IL-3-dependent murine5' and human" myeloid cell lines with either IL-3 or GM-CSF stimulates tyrosine phosphorylation of c-rui a 74-Kd protein. Thus, it is tempting to speculate that the 74-Kd protein documented in the present study may be c-ruj In addition, studies in PDGF-stimulated Swiss 3T3 fibroblasts have shown that several tyrosine phosphoproteins of similar molecular weights to those reported in the present study coimmunoprecipitate with the PDGF recepThese proteins have been identified as PLC-y (140 Kd), GAP (120 Kd), PI-3 kinase (85 Kd), and c-ruf(74 Kd). While the precise nature and function of this PDGF receptor signaling complex requires clarification, it has further been postulated that the association of these proteins with the PDGF receptor is vital to the function of the PDGF signal transduction pathway. The determination of an equivalent GM-CSF receptor signaling complex in neutrophils as well as the identification of the phosphotyrosine proteins documented in the present report awaits the availability of antihuman GM-CSF receptor antibodies for coimmunoprecipitation studies.
